• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Venture

SHS III reaches first closing on EUR40m

  • 01 May 2008
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Fund

SHS Gesellschaft fur Beteiligungsmanagement has achieved a first closing of SHS III on EUR40m. Following this, SHS expects to close its SHS III fund with a volume of EUR70m by the end of 2008. The SHS team contributed with a 5% subscription to the fund volume by first closing. The Tubingen-based fund's lifespan is 10 years, with two years expansion possible. The mimimum subscription is EUR500,000 and the hard cap is set at EUR80m. The terms and conditions are described as industry standard. 20% of the fund is held as a reserve for follow-on rounds.

P+P Pollath + Partners provided legal advice.

Investors

Investors are exclusively from Europe, with the majority located in Germany. Numbered among the investors are the European Investment Fund (EIF), through which the SHS fund has received support from the European Recovery Programme (ERP)-EIF Dachfonds and the Competitiveness and Innovation Framework Programme (CIP) set up by the European Union, the Kreditanstalt fur Wiederaufbau (KfW), a pension fund, funds-of-funds as well as various entrepreneurs and family offices. EIF and KfW act as cornerstone investors.

Investments

In common with its predecessor funds, SHS III will invest an average of EUR3m in attractive undertakings with marketable products in the field of life sciences and healthcare, especially in fields that offer rapid and substantial growth opportunities for young companies. This will particularly include medical technology and supplies, diagnostics and platform and production technologies. The fund plans to conclude two to three investments per year, and might co-invest.

The new fund is already engaged in discussions with the first potential candidates in its target sectors. The fund will invest in Germany, Austria and Switzerland in early stage companies.

The SHS team will not only contribute capital but also management expertise and capacity to its portfolio companies in order to underpin development and expansion.

People

Hubertus Leonhardt and Bernhard Schirmers were in charge of fundraising for SHS III.

Name: SHS III

Target: 70m

Focus: Life sciences, healthcare, later stage venture capital, Germany, Austria, Switzerland

Contact: SHS Gesellschaft fur Beteiligungsmanagement mbH

Address: Bismarckstrasse 12, 72072 Tubingen

Tel: + 49 (0) 7071 9169-100

Fax: + 49 (0) 7071 9169-190

P+P Pollath + Partners (Legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Venture
  • DACH

More on Venture

Redalpine expands leadership team amid CHF 1bn-plus fundraise
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities
VC Profile: RTP Global gears up to deploy largest fund to date, remains bullish on breakout opportunities

Partner Gareth Jefferies discusses early-stage deployment plans and advantages of supporting startups throughout their lifecycle

  • Venture
  • 14 August 2023
Medicxi raises USD 400m to invest in single-focus life sciences companies
Medicxi raises USD 400m to invest in single-focus life sciences companies

GP's fourth fund will deploy USD 10m-USD 20m tickets in narrow indications of unmet need; backed by pharma

  • Venture
  • 27 July 2023
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline
Women in PE: Earth Capital's Bezuidenhoudt and Hockley on 2024 fund launch progress and co-investment pipeline

UK-based impact investorт€™s female leaders discuss deployment plans and the advantages of its syndicate co-investment strategy

  • Venture
  • 21 July 2023

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013